MMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer

被引:37
作者
Li, Yanlei [1 ]
Sun, Baocun [1 ,2 ]
Zhao, Xiulan [1 ,2 ]
Wang, Xudong [3 ]
Zhang, Danfang [1 ,2 ]
Gu, Qiang [1 ,2 ]
Liu, Tieju [1 ,2 ]
机构
[1] Tianjin Med Univ, Dept Pathol, Tianjin, Peoples R China
[2] Tianjin Med Univ, Tianjin Canc Hosp, Dept Pathol, Tianjin, Peoples R China
[3] Tianjin Med Univ Canc Inst & Hosp, Dept Maxillofacial & Otorhinolaryngol Head & Neck, Tianjin, Peoples R China
基金
中国国家自然科学基金;
关键词
MMP-2; MMP-13; large cell lung cancer; vasculogenic mimicry; laminin5; EXTRACELLULAR-MATRIX; ACTIN-CYTOSKELETON; HEPATOCELLULAR-CARCINOMA; TUMOR-GROWTH; ANGIOGENESIS; METASTASIS; LAMININ-5; MELANOMA; EGF; METALLOPROTEINASE-13;
D O I
10.1111/jcmm.13283
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Matrix metalloproteinases (MMPs) have critical functions in tumour vasculogenic mimicry (VM). This study explored the mechanisms underlying MMP-13 and MMP-2 regulation of tumour VM formation in large cell lung cancer (LCLC). In our study, laminin5 (Ln-5) fragments cleaved by MMP-2 promoted tubular structure formation by the LCLC cell lines H460 and H661 in three-dimensional (3D) cultures. Transient up-regulation of MMP-13 or treatment with recombinant MMP-13 protein abrogated tubular structure formation of H460 cells in 3D culture. Treated cells with Ln-5 fragments cleaved by MMP-2 stimulated EGFR and F-actin expression. Ln-5 fragments cleaved by MMP-13 decreased EGFR/F-actin expression and disrupted VM formation. MMP-13 expression was negatively correlated with VM, Ln-5 and EGFR in LCLC tissues and xenograft. In vivo experiments revealed that VM was decreased when the number of endothelium-dependent vessels (EDVs) increased during xenograft tumour growth, whereas MMP-13 expression was progressively increased. In conclusion, MMP-2 promoted and MMP-13 disrupted VM formation in LCLC by cleaving Ln-5 to influence EGFR signal activation. MMP-13 may regulate VM and EDV formation.
引用
收藏
页码:3741 / 3751
页数:11
相关论文
共 31 条
[1]   Remodelling the extracellular matrix in development and disease [J].
Bonnans, Caroline ;
Chou, Jonathan ;
Werb, Zena .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (12) :786-801
[2]   Molecular mechanisms and clinical applications of angiogenesis [J].
Carmeliet, Peter ;
Jain, Rakesh K. .
NATURE, 2011, 473 (7347) :298-307
[3]   Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives [J].
Cheng, Xinghua ;
Chen, Haiquan .
ONCOTARGETS AND THERAPY, 2014, 7 :1689-1704
[4]  
Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO
[5]  
2-R
[6]   Alternative vascularization mechanisms in cancer -: Pathology and therapeutic implications [J].
Dome, Balazs ;
Hendrix, Mary J. C. ;
Paku, Sandor ;
Tovari, Jozsef ;
Timar, Jozsef .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (01) :1-15
[7]   The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis [J].
Fink, Krzysztof ;
Boratynski, Janusz .
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 :609-628
[8]  
Fischer OM, 2003, BIOCHEM SOC T, V31, P1203
[9]   Interaction between PARP-1 and HIF-2α in the hypoxic response [J].
Gonzalez-Flores, A. ;
Aguilar-Quesada, R. ;
Siles, E. ;
Pozo, S. ;
Rodriguez-Lara, M. I. ;
Lopez-Jimenez, L. ;
Lopez-Rodriguez, M. ;
Peralta-Leal, A. ;
Villar, D. ;
Martin-Oliva, D. ;
del Peso, L. ;
Berra, E. ;
Oliver, F. J. .
ONCOGENE, 2014, 33 (07) :891-898
[10]   Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin γ2 chain [J].
Koshikawa, N ;
Minegishi, T ;
Sharabi, A ;
Quaranta, V ;
Seiki, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (01) :88-93